Pear Suite Closes Seed Round | Week of May 16, 2023 | StartUp Health Insights

The StartUp Health portfolio company’s care navigation software and collaborations are expanded thanks to the seed funding, which has a specific focus on tackling social determinants of health while being culturally competent.

Pear Suite, a firm in the StartUp Health portfolio that aims to strengthen community health professionals’ abilities and better address social determinants of health (SDOH), has announced the completion of $2.5 million in seed funding. By focusing on the full person rather than simply the patient, Pear Suite’s SaaS platform assists businesses in enhancing well-being and lowering healthcare expenses. Pear Suite is a care navigation tool that equips community health professionals and translates data on social determinants of health into solutions that can be implemented. Anyone may more accurately assess and address the social drivers of health using Pear Suite’s cloud-based platform in a scalable, economical, and person-centered manner, including community health professionals, care coordination staff, volunteers, etc.

The money will help the Honolulu, Hawaii-based business grow its initiatives within the Asian American and Pacific Islander population and assist community health workers in acting more effectively on SDOH data. With backing from Techstars, Open Venture Capital, Incisive Ventures, Lair East Labs, StartUp Health, and Third Act Ventures, the investment round was spearheaded by Mucker Capital, Impact Engine, the American Heart Association, Sweater Ventures, and Atento Capital. <source>

A Solution for Healthcare, and Every thing Else?

Other health innovation funding reported this week included:

Amino Health, a San Francisco, California-based provider of digital healthcare advice, raised $80M in funding, with help from Oxford Finance and Transformation Capital. <source>

General Catalyst and Andreessen Horowitz (A16z) co-led the $50 million funding round for Hippocratic AI, a Palo Alto, California-based startup developing artificial intelligence models for the healthcare sector. <source>

Embr Labs, a company situated in Boston, Massachusetts that creates a wearable to treat menopausal symptoms, raised $35M in funding led by GT Investment Partners in partnership with Aon plc. <source>

A provider of a care concierge platform called Wellthy, based in New York, NY, secured $25.5M from Citi Impact Fund, Cercano Management, and Stardust Equity. <source>

Marshall Wace and Safeguard Scientifics co-led the $23M funding round for Prognos Health, a real-world integrated data marketplace based in New York, NY. Other investors included Cigna Ventures, Hikma Ventures, Hunt Holdings, Labcorp, Maywic, Merck Global Health Innovation Fund, and Red and Blue Ventures.

With participation from PJC, GenHenn Capital, and FCA Venture Partners, Diligent Pharma, a vendor qualification and risk management platform for clinical trials, raised $8.27 million.

Camford Capital and angel investors helped Lavita AI, a San Francisco, California-based supplier of an AI+Web3 healthcare platform, raise $5M.

With cooperation from Investissement Quebec, The51 Ventures, Sheboot, and angel investors, FemTherapeutics, a medical technology firm based in Montreal, Ontario, Canada that creates customised gynaecological prostheses for women with pelvic floor issues, acquired $1.85 million in funding. 2048 Ventures served as the lead investor.

Cascade Health, a Seattle, Washington-based company that offers a platform for healthcare transparency, raised $1.7M in a round that was led by AlleyCorp and included angel investors. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. 

Content Protection by

Back to top button